Primecap Management CO Bio N Tech Se Call Options Transaction History
Primecap Management CO
- $118 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
335Shares Held
39.8MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$909 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$475 Million1.71% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$211 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.84% of portfolio
-
Capital International Investors Los Angeles, CA1.43MShares$159 Million0.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...